Bellicum Pharmaceuticals, Inc.
BLCM · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | -$10 | -$8 | -$112 |
| Dep. & Amort. | $0 | $0 | $2 | $9 |
| Deferred Tax | $0 | -$15 | -$49 | $24 |
| Stock-Based Comp. | $3 | $3 | $5 | $7 |
| Change in WC | -$1 | -$2 | -$8 | -$7 |
| Other Non-Cash | -$2 | $0 | $1 | $2 |
| Operating Cash Flow | -$26 | -$23 | -$57 | -$78 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $49 |
| Other Inv. Act. | $0 | $1 | $15 | $0 |
| Investing Cash Flow | -$0 | $1 | $14 | $49 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $23 | $9 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $33 | -$14 | $74 |
| Financing Cash Flow | $0 | $33 | -$14 | $74 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$26 | $11 | -$57 | $45 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48 | $37 | $94 | $49 |
| End Cash | $22 | $48 | $37 | $94 |
| Free Cash Flow | -$26 | -$23 | -$57 | -$78 |